AzTrials
AzTrials

Acute Malnutrition in ChildhoodELOFSAMNCT06103084

Effectiveness of Local Food Solutions for the Prevention of Acute Malnutrition in Tigray, Northern Ethiopia (ELOFSAM)

A study testing Bahgina and SQLNS in people with Acute Malnutrition in Childhood, run by Mekelle University at 1 site in Ethiopia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The lack of diversified and enriched complementary foods is one of the key causes of the high burden of acute malnutrition among 6-23 months old children in Ethiopia. Thus, a new innovative way of diversifying and enriching complementary foods is essential in communities where vulnerable populations are likely to have… Read more about this study

Who is it for?
Ages 6 to 23 monthsHealthy volunteers can take part
Conditions the study is for
Acute Malnutrition in Childhood
What is being tested?
Bahgina and SQLNS
Could I receive a placebo?
No, everyone receives an active treatment
How many people
7,530 participants
Where
1 siteEthiopia
Study dates
30 Jun 2023to 28 Feb 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 23 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • All 6-23 months old children

Who cannot join

  • 6-23 months old children with severe acute malnutrition.

Trial locations and contacts

1 site in 1 country.

Afework Mulugeta, PhD contact

+251 914 382045

afework.mulugeta@gmail.com

Kidanemariam Alem, MSc contact

+251921645753

kidanemariam2012@gmail.com

Ethiopia1 site, 1 recruiting
  • Tigray Health Research Institute

    Mek'ele, Tigray, 1547

    Hayelom Kahsay, MD, +251937404971, hayelomk21@gmail.com

    Afework Mulugeta, PhD

    Recruiting

Other trials in Ethiopia

About this study

Official title: Acceptability and Effectiveness of Local Food Solutions for the Prevention of Acute Malnutrition in Tigray, Northern Ethiopia (ELOFSAM)

The lack of diversified and enriched complementary foods is one of the key causes of the high burden of acute malnutrition among 6-23 months old children in Ethiopia. Thus, a new innovative way of diversifying and enriching complementary foods is essential in communities where vulnerable populations are likely to have nutrient gaps in their typical diets and multiple micronutrient deficiencies. The purpose of this project is to investigate the acceptability and effectiveness of locally produced cereal based foods (LP-CBFs) and small quantity lipid based nutrient supplements (SQ-LNS) as preventive interventions to effectively reduce the burden of acute malnutrition among 6-23 months old children in the post conflict settings of Tigray, Northern Ethiopia.

Being tested
Bahgina, SQLNS

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BahginaDietary supplement

    Bahgina, a locally produced cereal based food, will be provided at 200g/day/child for a duration of six months on top of the routine nutrition services provided by the local government and nutrition partners.

  • SQLNSDietary supplement

    Small quantity lipid based nutrient supplement (SQ-LNS) will be provided at 20g/day/child for a duration of six months on top of the routine nutrition services provided by the local government and nutrition partners.

Study groups in NCT06103084
Study groupRoleWhat they receive
Bahgina groupExperimentalThe Bahgina treatment group will be supplemented with Bahgina, a locally produced cereal based product for a maximum of six months at 200g/day.
Receives: Dietary Supplement: Bahgina
SQLNS groupExperimentalThe small quantity lipid based nutrient supplements (SQLNS) group will be provided with 20g of SQLNS/day for a maximum of six months.
Receives: Dietary Supplement: SQLNS
ControlNo interventionThe control group will get nothing except the routine nutrition services and products provided by the local government sectors.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acute Malnutrition

    The burden or prevalence of acute malnutrition among 6-23 months old children.

    Measured: six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2023
  2. Study start30 Jun 2023
  3. Primary completion30 Dec 2023 (estimated)
  4. Study completion28 Feb 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
7,530 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06103084
Sponsor's protocol ID
MUCHS
Acronym
ELOFSAM
Status last verified
Oct 2023
First submitted
22 Oct 2023
Last updated
26 Oct 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Bahgina and SQLNS in people with Acute Malnutrition in Childhood, run by Mekelle University at 1 site in Ethiopia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ethiopia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Afework Mulugeta, PhD (+251 914 382045, afework.mulugeta@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acute Malnutrition (time frame: six months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in